Navigation Links
European Union Grants a Good Manufacturing Practice Certificate to Nelson Laboratories
Date:8/20/2013

SALT LAKE CITY, Aug. 20, 2013 /PRNewswire/ -- Nelson Laboratories today announced the successful receipt of the European Union's Good Manufacturing Practice (GMP) Compliance Certificate after the Medicines and Healthcare products Regulatory Agency (MHRA) inspection of the laboratory's facilities and processes.

(Logo: http://photos.prnewswire.com/prnh/20120727/LA47745LOGO)

"Manufacturers are obligated to defend their products and the supporting testing data," said Jeff Hone, vice president of quality at Nelson Laboratories. "The GMP certification for Nelson Laboratories satisfies the requirements of the testing laboratory quality system as set by the EU Commission. This certification will help expedite approval of products tested under our certified quality management systems."

The MHRA is an executive agency of the United Kingdom Department of Health and is responsible for regulating all medicines and medical devices in the UK by ensuring they work and are acceptably safe. The MHRA, acting as an authorized representative of the EU, performs quality system inspections to assess the degree of conformity to prescribed relevant regulatory requirements of Good Manufacturing Practice established by EU compliance.

"Europe has established standards for handling new medical devices that are different from the FDA," added Hone. "Nelson Laboratories has been helping manufacturers get devices to market by staying current with both FDA and European trends and regulations. Now that Nelson Laboratories is certified in Europe, it will be even easier for sponsors interested in marketing devices there."

About Nelson Laboratories
Nelson Laboratories is a leading provider of full, life-cycle microbiology testing services. We are known for exceptional quality, but we look beyond the testing process and collaborate with you to achieve your long-term business goals. It's what we call The Science of Success™. It's transparency in the testing process. It's approachable experts that guide you through ever-changing compliance requirements. It's helping you mitigate risk, be first to market, and succeed with your customers. Learn more at www.nelsonlabs.com.

PR Contact:

Ryan Oaks
Snapp Conner PR
801-994-9625
ryan@snappconner.com 


'/>"/>
SOURCE Nelson Laboratories
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Orexigen Therapeutics Announces European Filing Strategy and Reports Business and Financial Results for the Second Quarter Ended June 30, 2013
2. European Urological Device Market Will Be Driven By Adoption Of New Minimally Invasive Devices
3. CryoLife Announces First European Implant Of HeRO Graft
4. The Emerging Eastern European Market For Interventional Cardiology Devices Will Grow To $282 Million By 2021
5. Mature US and European coronary artery bypass graft device markets will Shrink through 2021
6. US and European Computer Aided Detection (CAD) Industry
7. EAACI Publishes the First European Guidelines for food-Allergy Sufferers
8. Sorrento Therapeutics and IGDRASOL to Present Late Stage Clinical Data Updates on their Oncology Nanomedicine Platform at the Joint Meeting of the European Foundation for Clinical Nanomedicine and European Technology Platform on Nanomedicine in Base
9. European Orthopedic Market 2017 Forecasts: Hip, Knee & Shoulder Analysis in New Research Report at ReportsnReports.com
10. Surveyed U.S. and European Neurologists Identify Better Seizure-Free Efficacy as One of the Greatest Unmet Needs in Treating Partial-Onset Seizures in Refractory Epilepsy Patients
11. U.S. and European Rheumatologists Agree That a Therapys Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... British Columbia , December 2, 2016 bioLytical ... bekannt gegeben, ab diesem Monat seinen  INSTI HIV-Selbsttests  in einer Version mit ... ... New: INSTI Self Test! ... , ,      (Photo: ...
(Date:12/2/2016)... The iShares Nasdaq Biotechnology Exchange-Traded Fund ... victory early in November. Less political risk has boosted ... predicting an uptick in M&A activities. Today, Stock-Callers.com takes ... they have fared at the last close: Celldex Therapeutics ... (NASDAQ: FOLD ), Navidea Biopharmaceuticals Inc. (NYSE ...
(Date:11/30/2016)... Nov 30, 2016 Research and ... Overview for Neuromodulation, Neurovascular, Neurosurgical and Monitoring Devices 2017 - ... ... The full report suite on the U.S. market ... drainage systems, intracranial pressure monitoring devices, detachable coils, liquid embolics, ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... On Dec. 2, 2016, CURE® magazine will ... Diego honoring the 2016 MPN Heroes—eight individuals who have made a difference in the ... beyond the standard of care, demonstrating leadership within the MPN community and/or a commitment ...
(Date:12/2/2016)... ... December 02, 2016 , ... More than 100 business, civic, ... to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. This inaugural event, ... and operating support to UNCF-member institutions, including Miles College, Oakwood University, Tuskegee University, ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... launch of its 60-day free trial program for all of the company’s desktop ... offer a truly hassle free experience. , FlexiSpot’s unique desktop risers use an ...
(Date:12/2/2016)... ... 2016 , ... The annual time frame to change Medicare health and prescription ... December 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their current plan ... to make changes during this period order for their new policy to go into ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain ... an injury, patients must find the one that works for them. When an inventor ... a machine that worked and decided to share it with others. , He developed ...
Breaking Medicine News(10 mins):